Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 11/20 | 0.67 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.67 |
| ▸ | TUBB | P07437 | 1/20 | 0.67 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.67 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.67 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.67 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.67 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.67 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.67 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.67 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.67 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.67 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.67 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.67 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.67 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.55 |
| ▸ | HPGD | P15428 | 7/20 | 0.55 |
| ▸ | MEN1 | O00255 | 4/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Confusameline SCHEMBL21784044 | 0.84 | KDM4E (0.65) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| Confusameline SCHEMBL30525089 | 0.84 | KDM4E (0.65) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| Kokusaginine SCHEMBL23870280 | 0.80 | KDM4E (1.00) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| Kokusaginine SCHEMBL30609976 | 0.80 | KDM4E (1.00) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| Dictamnine SCHEMBL1760700 | 0.80 | POLB (0.65) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| Maculine SCHEMBL29461401 | 0.75 | KDM4E (0.66) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| Maculine SCHEMBL30361505 | 0.75 | KDM4E (0.66) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL12466681 | 0.74 | KDM1A (0.47) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL31214315 | 0.74 | ALDH1A1 (0.66) | KDM4ETUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL12466494 | 0.71 | PHLPP2 (0.53) | KDM4ETUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12310952-B2 | Traditional Chinese drug monomer composition for treating Helicobacter pylori, preparation method and use thereof | YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES (CN) | 2025-05-27 | — | — | US | claimed |
| US-20240316013-A1 | TRADITIONAL CHINESE DRUG MONOMER COMPOSITION FOR TREATING HELICOBACTER PYLORI, PREPARATION METHOD AND USE THEREOF | YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITES (CN) | 2024-09-26 | — | — | US | claimed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-12310952-B2 | Traditional Chinese drug monomer composition for treating Helicobacter pylori, preparation method and use thereof | YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES (CN) | 2025-05-27 | — | — | US | disclosed |
| US-12310952-B2 | Traditional Chinese drug monomer composition for treating Helicobacter pylori, preparation method and use thereof | YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITIES (CN) | 2025-05-27 | — | — | US | disclosed |
| US-20240316013-A1 | TRADITIONAL CHINESE DRUG MONOMER COMPOSITION FOR TREATING HELICOBACTER PYLORI, PREPARATION METHOD AND USE THEREOF | YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITES (CN) | 2024-09-26 | — | — | US | disclosed |
| US-20240316013-A1 | TRADITIONAL CHINESE DRUG MONOMER COMPOSITION FOR TREATING HELICOBACTER PYLORI, PREPARATION METHOD AND USE THEREOF | YOUJIANG MEDICAL UNIVERSITY FOR NATIONALITES (CN) | 2024-09-26 | — | — | US | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240207344-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207342-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240108676-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-04-04 | — | — | US | disclosed |
| US-11883454-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230405067-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2023-12-21 | — | — | US | disclosed |
| US-20220387537-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2022-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | KDM4E 2069/4885TUBB4A 2451/4885TUBB 2860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.